about
Metformin protects skeletal muscle from cardiotoxin induced degenerationProline oxidase-adipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation.FoxO1 controls lysosomal acid lipase in adipocytes: implication of lipophagy during nutrient restriction and metformin treatment.Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human.Inhibition of age-related cytokines production by ATGL: a mechanism linked to the anti-inflammatory effect of resveratrol.Managing lipid metabolism in proliferating cells: new perspective for metformin usage in cancer therapy.The role of nNOS and PGC-1α in skeletal muscle cells.Caloric Restriction and the Nutrient-Sensing PGC-1α in Mitochondrial Homeostasis: New Perspectives in Neurodegeneration.Maternal high calorie diet induces mitochondrial dysfunction and senescence phenotype in subcutaneous fat of newborn mice.Intermittent Fasting Applied in Combination with Rotenone Treatment Exacerbates Dopamine Neurons Degeneration in Mice.Pushing the Limits of Cancer Therapy: The Nutrient Game.Time-controlled fasting prevents aging-like mitochondrial changes induced by persistent dietary fat overload in skeletal muscle.Glutathione transferase P silencing promotes neuronal differentiation of retinal R28 cellsRedox control of non-shivering thermogenesisNrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich's Ataxia Neural Stem CellsFrataxin deficiency induces lipid accumulation and affects thermogenesis in brown adipose tissueAdipocyte metabolism is improved by TNF receptor-targeting small RNAs identified from dried nutsFoxO1 localizes to mitochondria of adipose tissue and is affected by nutrient stress
P50
Q28542422-517221B0-50C9-4216-A62E-A48FF7CBB183Q37379416-F41FD154-3956-4899-BE0D-51B36FE49D14Q37577484-F843FFAE-AC72-4B86-854D-F571096996B4Q37610197-83D1A090-7C84-4E71-ACAC-45F4274DBC84Q37725562-943C1F7A-48A3-46AC-BA10-6FB35801B10EQ38191104-E029A72D-999E-4FC9-A7CF-418BF601BEADQ38248829-1ADD2E13-2B6E-4DE6-98C2-219D873740A3Q41885050-4A673A48-F86B-4767-AB3D-5BE2F0725A87Q47112564-734B5A8C-BADC-44AF-8314-E9957815D44CQ47827804-644C261B-0EFA-4452-A1FA-072B83B0EA45Q54959664-9EE0583D-281B-41CE-9BF1-B525D8B06E3DQ55030789-90B065EB-FC6E-405C-A5E2-90F10DA33BBFQ64040661-68772768-8D8E-4E23-AE5F-2290982990ACQ90040349-09B5681C-A40D-4ED8-8490-594C8F5D249EQ92649323-4AE2E102-3177-4090-891E-F2D7E5C1AABAQ92889829-60349A03-7C18-4489-AFC7-FF6D7D4F6166Q92894362-D0A45352-E0E8-4DE0-8596-99C21B2B8B62Q93027906-C0EF7140-4007-46B8-9463-61CCC52671A6
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1172-814X
@en
name
Daniele Lettieri Barbato
@ast
Daniele Lettieri Barbato
@en
Daniele Lettieri Barbato
@es
Daniele Lettieri Barbato
@nl
type
label
Daniele Lettieri Barbato
@ast
Daniele Lettieri Barbato
@en
Daniele Lettieri Barbato
@es
Daniele Lettieri Barbato
@nl
prefLabel
Daniele Lettieri Barbato
@ast
Daniele Lettieri Barbato
@en
Daniele Lettieri Barbato
@es
Daniele Lettieri Barbato
@nl
P106
P1153
53264259000
P31
P496
0000-0002-1172-814X